Aviv Regev, executive vice president and head of Genentech Research & Early Development (gRED) NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s ...
The life sciences are entering a decisive new phase. Over the past decade, artificial intelligence (AI) has proven its value as a powerful tool, helping researchers analyse vast datasets, surface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results